Home > M&A deals 2018 > CytoBioscience, Inc. acquires BioDtech, Inc.
Add-on Acquistion · Life Science · November 2018

CytoBioscience, Inc. acquires BioDtech, Inc.

On November 28, 2018, CytoBioscience, Inc. acquired BioDtech, Inc., a life science company in Alabama, United States, from Greer Capital Advisors LLC.

Deal at a glance

AnnouncedNovember 28, 2018 TypeAdd-on Acquistion TargetBioDtech, Inc. Buyer CytoBioscience, Inc. Seller Greer Capital Advisors LLC SectorLife Science LocationAlabama, United States ValueNot disclosed

Target company

BioDtech, Inc.
Alabama, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Company · 2 deals on record
  • 2nd transaction in life science
  • 2nd transaction in United States
2deals, all time
2in this sector
2018latest

Seller

Private equity firm · 20 deals on record
20investments
16in this sector
11exits

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired BioDtech, Inc.?CytoBioscience, Inc. acquired BioDtech, Inc. on November 28, 2018.

Who sold BioDtech, Inc.?Greer Capital Advisors LLC was the seller.

What type of deal was it?It was a add-on acquistion in the life science sector in 2018.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).